Potential role of metabolomic approaches for Chinese medicine syndromes and herbal medicine

Phytotherapy Research

Volumn 26, Issue 10, 2012, Pages 1466-1471

  Sun, Hui ^a   Zhang, Aihua ^a   Wang, Xijun ^a  

^a HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

biomarkers; Chinese medicine syndromes; herbal medicine; metabolites; metabolomics; personalized medicine; systems biology; traditional Chinese medicine

Indexed keywords

BIOLOGICAL MARKER; HERBACEOUS AGENT;

ACONITE; ACONITUM CARMICHAELII; ARTHRALGIA; BINDING AFFINITY; CHINESE MEDICINE; CHRONIC HEPATITIS; DRUG BINDING; EVIDENCE BASED MEDICINE; HERBAL MEDICINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INSOMNIA; ISCHEMIC HEART DISEASE; MASS SPECTROMETRY; METABOLOMICS; NEPHROTIC SYNDROME; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PLANT ROOT; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SYSTEMS BIOLOGY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; UNSPECIFIED SIDE EFFECT;

BIOLOGICAL MARKERS; DRUGS, CHINESE HERBAL; HERBAL MEDICINE; HUMANS; MEDICINE, CHINESE TRADITIONAL; METABOLOMICS;

EID: 84867336643     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4613     Document Type: Review

References (71)

1. Arakaki AK, Skolnick J, McDonald JF,. 2008. Marker metabolites can be therapeutic targets as well. Nature 456: 443. [PubMed: 19037294]
2. Baraldi E, Carraro S, Giordano G, Reniero F, Perilongo G, Zacchello F,. 2009. Metabolomics: moving towards personalized medicine. Ital J Pediatr 35: 30. [PubMed: 19852788]
3. Bathen TF, Sitter B, Sjøbakk TE, Tessem MB, Gribbestad IS,. 2010. Magnetic resonance metabolomics of intact tissue: a biotechnological tool in cancer diagnostics and treatment evaluation. Cancer Res 70: 6692-6696. [PubMed: 20699363]
4. Blow N,. 2008. Metabolomics: Biochemistry's new look. Nature 455: 697-700. [PubMed: 18833281]
5. Brown PO, Palmer C,. 2009. The preclinical natural history of serous ovarian cancer: defining the target for early detection. PLoS Med 6: e1000114. [PubMed: 19636370]
6. Chan EC, Pasikanti KK, Nicholson JK,. 2011. Global urinary metabolic profiling procedures using gas chromatography-mass spectrometry. Nat Protoc 6: 1483-1499. [PubMed: 21959233]
7. Chen M, Zhao L, Jia W,. 2005. Metabonomic study on the biochemical profiles of a hydrocortisone-induced animal model. J Proteome Res 4: 2391-2396. [PubMed: 16335992]
8. Clayton TA, Lindon JC, Cloarec O, et al., 2006. Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature 440: 1073-1077. [PubMed: 16625200]
9. Coen M, Want EJ, Clayton TA, et al., 2009. Mechanistic aspects and novel biomarkers of responder and non-responder phenotypes in galactosamine-induced hepatitis. J Proteome Res 8: 5175-5187. [PubMed: 19821561]
10. Cooks RG, Ouyang Z, Takats Z, Wiseman JM,. 2006. Detection technologies. Ambient mass spectrometry. Science 311: 1566-1570. [PubMed: 16543450].
11. Davis CD, Milner JA,. 2007. Biomarkers for diet and cancer prevention research: potentials and challenges. Acta Pharmacol Sin 28: 1262-1273. [PubMed: 17723162]
12. De Bono JS, Ashworth A,. 2010. Translating cancer research into targeted therapeutics. Nature 467: 543-549. [PubMed: 20882008]
13. Ding L, Hao F, Shi Z, et al., 2009. Systems biological responses to chronic perfluorododecanoic acid exposure by integrated metabonomic and transcriptomic studies. J Proteome Res 8: 2882-2891. [PubMed: 19378957]
14. Fiehn O,. 2002. Metabolomics-the link between genotypes and phenotypes. Plant Mol Biol 48: 155-171. [PubMed: 11860207]
15. Gazdar AF,. 2009. Personalized medicine and inhibition of EGFR signaling in lung cancer. N Engl J Med 361: 1018-1020. [PubMed: 19692681]
16. Godzien J, Ciborowski M, Angulo S, et al., 2011. Metabolomic approach with LC-QTOF to study the effect of a nutraceutical treatment on urine of diabetic rats. J Proteome Res 10: 837-844. [PubMed: 21087057]
17. Greensfelder L,. 2000. Alternative medicine. Herbal product linked to cancer. Science 288: 1946. [PubMed: 10877707]
18. Griffiths WJ, Koal T, Wang Y, Kohl M, Enot DP, Deigner HP,. 2010. Targeted metabolomics for biomarker discovery. Angew Chem Int Ed Engl 49: 5426-5445. [PubMed: 20629054]
19. Hamburg MA, Collins FS,. 2010. The path to personalized medicine. N Engl J Med 363: 301-304. [PubMed: 20551152]
20. Holmes E, Wilson ID, Nicholson JK,. 2008. Metabolic phenotyping in health and disease. Nature 453: 396-401. [PubMed: 18425110]
21. Hood L, Heath JR, Phelps ME, Lin B,. 2004. Systems biology and new technologies enable predictive and preventative medicine. Science 306: 640-643. [PubMed: 15499008]
22. Jian WX, Yuan ZK, Huang XP,. 2010. Detection and analysis on plasma metabolomics in patient with coronary heart disease of Xin-blood stasis syndrome pattern. Zhongguo Zhong Xi Yi Jie He Za Zhi 30: 579-584. [PubMed: 20815270]
23. Kinross JM, Holmes E, Darzi AW, Nicholson JK,. 2011. Metabolic phenotyping for monitoring surgical patients. Lancet 377: 1817-1819. [PubMed: 21596428]
24. Klayman DL,. 1985. Qinghaosu (artemisinin): an antimalarial drug from China. Science 228: 1049-1055. [PubMed: 3887571]
25. Kotłowska A, Sworczak K, Stepnowski P,. 2011. Urine metabolomics analysis for adrenal incidentaloma activity detection and biomarker discovery. J Chromatogr B Analyt Technol Biomed Life Sci 879: 359-363. [PubMed: 21247813]
26. Kussmann M, Panchaud A, Affolter M,. 2010. Proteomics in nutrition: status quo and outlook for biomarkers and bioactives. J Proteome Res 9: 4876-4887. [PubMed: 20718507]
27. Li JW, Vederas JC,. 2009. Drug discovery and natural products: end of an era or an endless frontier? Science 325: 161-165. [PubMed: 19589993]
28. Liang ZH, Yin DZ,. 2010. Preventive treatment of traditional Chinese medicine as antistress and antiaging strategy. Rejuvenation Res 13: 248-252. [PubMed: 19954331]
29. Lindon JC, Holmes E, Bollard ME, Stanley EG, Nicholson JK,. 2004. Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis. Biomarkers 9: 1-31. [PubMed: 15204308]
30. Liu JY, Li N, Yang J, et al., 2010. Metabolic profiling of murine plasma reveals an unexpected biomarker in rofecoxib-mediated cardiovascular events. Proc Natl Acad Sci USA 107: 17017-17022. [PubMed: 20837537]
31. Lu X, Z Xiong, J Li, S Zheng, T Huo, F Li,. 2011. Metabonomic study on 'Kidney-Yang Deficiency syndrome' and intervention effects of Rhizoma Drynariae extracts in rats using ultra performance liquid chromatography coupled with mass spectrometry. Talanta 83: 700-708. [PubMed: 21147309]
32. Manna SK, Patterson AD, Yang Q, et al., 2010. Identification of noninvasive biomarkers for alcohol-induced liver disease using urinary metabolomics and the Ppara-null mouse. J Proteome Res 9: 4176-4188. [PubMed: 20540569]
33. Minami Y, Kasukawa T, Kakazu Y, et al., 2009. Measurement of internal body time by blood metabolomics. Proc Natl Acad Sci USA 106: 9890-9895. [PubMed: 19487679]
34. Nicholson JK, Lindon JC,. 2008. Systems biology: Metabonomics. Nature 455: 1054-1056. [PubMed: 18948945]
35. Nicholson JK, Wilson ID,. 2003. Opinion: understanding 'global' systems biology: metabonomics and the continuum of metabolism. Nat Rev Drug Discov 2: 668-676.
36. Nicholoson JK, Connelly J, Lindon JC, Holmes E,. 2002. Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov 1: 153-161.
37. Nicholson JK, Wilson ID, Lindon JC,. 2010. Pharmacometabonomics as an effector for personalized medicine. Pharmacogenomics 12: 103-111.
38. Normile D,. 2003. Asian medicine: the new face of traditional Chinese medicine. Science 299: 188-190. [PubMed: 12522228]
39. Prestele J, Hierl G, Scherling C, et al., 2010. Different functions of the C3HC4 zinc RING finger peroxins PEX10, PEX2, and PEX12 in peroxisome formation and matrix protein import. Proc Natl Acad Sci USA 107: 14915-14920. [PubMed: 20679226]
40. Qiu J,. 2007. Traditional medicine: a culture in the balance. Nature 448: 126-128. [PubMed: 17625539]
41. Qiu Y, Chen M, Su M, et al., 2008. Metabolic profiling reveals therapeutic effects of Herba Cistanches in an animal model of hydrocortisone-induced 'kidney-deficiency syndrome'. Chin Med 10: 3-3. [PubMed: 18328110]
42. Rios-Estepa R, Turner GW, Lee JM, Croteau RB, Lange BM,. 2008. A systems biology approach identifies the biochemical mechanisms regulating monoterpenoid essential oil composition in peppermint. Proc Natl Acad Sci USA 105: 2818-2823. [PubMed: 18287058]
43. Rosenson RS,. 2010. New technologies personalize diagnostics and therapeutics. Curr Atheroscler Rep 12: 184-186. [PubMed: 20425257]
44. Sakamoto JH, van de Ven AL, Godin B, et al., 2010. Enabling individualized therapy through nanotechnology. Pharmacol Res 62: 57-89. [PubMed: 20045055]
45. Schnackenberg LK,. 2007, Global metabolic profiling and its role in systems biology to advance personalized medicine in the 21st century. Expert Rev Mol Diagn 7: 247-259. [PubMed: 17489732]
46. Shaham O, Slate NG, Goldberger O, et al., 2010. A plasma signature of human mitochondrial disease revealed through metabolic profiling of spent media from cultured muscle cells. Proc Natl Acad Sci USA 107: 1571-1575. [PubMed: 20080599]
47. Shroff R, Rulísek L, Doubsky J, Svatos A,. 2009. Acid-base-driven matrix-assisted mass spectrometry for targeted metabolomics. Proc Natl Acad Sci USA 106: 10092-10096. [PubMed: 19520825]
48. Sreekumar A, Poisson LM, Rajendiran TM, et al., 2009. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457: 910-914. [PubMed: 19212411]
49. Stone R,. Biochemistry. 2008. Lifting the veil on traditional Chinese medicine. Science 319: 709-710. [PubMed: 18258866]
50. Sun H, Ni B, Zhang A, Wang M, Dong H, Wang X,. 2012. Metabolomics study on Fuzi and its processed products using ultra-performance liquid- chromatography/electrospray-ionization synapt high-definition mass spectrometry coupled with pattern recognition analysis. Analyst 137: 170-185. [PubMed: 22030742]
51. Tolstikov VV, Fiehn O, Tanaka N,. 2007. Application of liquid chromatography-mass spectrometry analysis in metabolomics: reversed-phase monolithic capillary chromatography and hydrophilic chromatography coupled to electrospray ionization-mass spectrometry. Methods Mol Biol 358: 141-155. [PubMed: 17035685]
52. Tong X, Sun H, Yan GL, et al., 2011. Evaluation study on urine metabolomics in Yinhuang rat model induced by triplet factors of rhubarb, ethanol, and α-nephthylisothiolyanate. Chin J Integr Med 17: 369-375. [PubMed: 21611901]
53. Ulrich-Merzenich G, Panek D, Zeitler H, Wagner H, Vetter H,. 2009. New perspectives for synergy research with the 'omic'-technologies. Phytomedicine 16: 495-508. [PubMed: 19428231]
54. Van der Greef J, T Hankemeier, RN McBurney,. 2006. Metabolomics-based systems biology and personalized medicine: moving towards n = 1 clinical trials? Pharmacogenomics 7: 1087-1094. [PubMed: 17054418]
55. Van der Greef J, Martin S, Juhasz P, et al., 2007. The art and practice of systems biology in medicine: mapping patterns of relationships. J Proteome Res 6: 1540-1559. [PubMed: 17373844]
56. Van Wietmarschen H, Yuan K, Lu C, et al., 2009. Systems biology guided by Chinese medicine reveals new markers for sub-typing rheumatoid arthritis patients. J Clin Rheumatol 15: 330-337. [PubMed: 20009967]
57. Wang M, Lamers RJ, Korthout HA, et al., 2005. Metabolomics in the context of systems biology: bridging traditional Chinese medicine and molecular pharmacology. Phytother Res 19: 173-182. [PubMed: 15934013]
58. Wang P, Sun H, Lv H, et al., 2010. Thyroxine and reserpine-induced changes in metabolic profiles of rat urine and the therapeutic effect of Liu Wei Di Huang Wan detected by UPLC-HDMS. J Pharm Biomed Anal 53: 631-645. [PubMed: 20605388]
59. Wang X, Sun H, Zhang A, Jiao G, Sun W, Yuan Y,. 2011a. Pharmacokinetics screening for multi-components absorbed in the rat plasma after oral administration traditional Chinese medicine formula Yin-Chen-Hao-Tang by ultra performance liquid chromatography-electrospray ionization/quadrupole-time-of- flight mass spectrometry combined with pattern recognition methods. Analyst 23: 5068-5076. [PubMed: 21991580]
60. Wang X, Sun H, Zhang A, Sun W, Wang P, Wang Z,. 2011b. Potential role of metabolomics apporoaches in the area of traditional Chinese medicine: as pillars of the bridge between Chinese and Western medicine. J Pharm Biomed Anal 55: 859-868. [PubMed: 21353755]
61. Wang X, Wang H, Zhang A, et al., 2011c. Metabolomics study on the toxicity of aconite root and its processed products using ultraperformance liquid-chromatography/electrospray-ionization synapt high-definition mass spectrometry coupled with pattern recognition approach and ingenuity pathways analysis. J Proteome Res DOI: 10.1021/pr200963e. [PubMed: 22053844]
62. Want EJ, Wilson ID, Gika H, et al., 2010, Global metabolic profiling procedures for urine using UPLC-MS. Nat Protoc 5: 1005-1018. [PubMed: 20448546]
63. Wikoff WR, Anfora AT, Liu J, et al., 2009. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci USA 106: 3698-3703. [PubMed: 19234110]
64. Winnike JH, Li Z, Wright FA, Macdonald JM, O'Connell TM, Watkins PB,. 2010. Use of pharmaco-metabonomics for early prediction of acetaminophen-induced hepatotoxicity in humans. Clin Pharmacol Ther 88: 45-51. [PubMed: 20182423]
65. Xu F, Zou L, Ong CN,. 2009. Multiorigination of chromatographic peaks in derivatized GC/MS metabolomics: a confounder that influences metabolic pathway interpretation. J Proteome Res 8: 5657-5665. [PubMed: 19835423]
66. Xue T, Roy R,. 2003. Studying traditional Chinese medicine. Science 300: 740-741. [PubMed: 12730581]
67. Yan B, JiYe A, Hao HP, et al., 2009. Metabonomic phenotype and identification of 'heart blood stasis obstruction pattern' and 'qi and yin deficiency pattern' of myocardial ischemia rat models. Sci China C Life Sci 52: 1081-1090. [PubMed: 19937207]
68. Yang B, Zhang A, Sun H, et al., 2012. Metabolomic study of insomnia and intervention effects of Suanzaoren decoction using ultra-performance liquid-chromatography/electrospray-ionization synapt high-definition mass spectrometry. J Pharm Biomed Anal 58: 113-124. [PubMed: 22019702]
69. Zhang A, Sun H, Wang Z, Sun W, Wang P, Wang X,. 2010. Metabolomics: towards understanding traditional Chinese medicine. Planta Med 76: 2026-2035. [PubMed: 21058239]
70. Zhang A, Sun H, Yuan Y, Sun W, Jiao G, Wang X,. 2011. An in vivo analysis of the therapeutic and synergistic properties of Chinese medicinal formula Yin-Chen-Hao-Tang based on its active constituents. Fitoterapia 82 (8): 1160-1168. [PubMed: 21835230]
71. Zhang A, Sun H, Wang P, Han Y, Wang X,. 2012, Modern analytical techniques in metabolomics analysis. Analyst 137: 293-300. [PubMed: 22102985]